Product custom-nanocomposites-fluorescent-labeled-nanocomposites

Home > products > custom-nanocomposites> fluorescent-labeled-nanocomposites

Catalog	name	Description	price
R-Mcs-230	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiO-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiO-DBCO can encapsulate therapeutic agents, allowing for targeted and controlled drug delivery in oncology or other therapeutic applications.The fluorescent nature of DiO allows for visualization of the liposomes in biological systems, facilitating tracking of their distribution and uptake in cells.The DBCO functionalization enables the attachment of various biomolecules, which can help in specific targeting against disease markers or deliver imaging probes.Due to the presence of DOPS, these liposomes can facilitate immune responses and be harnessed in vaccine formulations.	price>
R-Mcs-231	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiR-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiR-DBCO can encapsulate therapeutic agents, allowing for targeted and controlled drug delivery in oncology or other therapeutic applications.The far-red fluorescence from DiR allows for non-invasive imaging of liposomes in vivo, useful for tracking distribution and pharmacokinetics.The DBCO moiety allows for the attachment of different biomolecules, creating a versatile platform for developing probes for diagnostics or therapeutic applications.	price>
R-Mcs-232	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based FluoroliposomeDansyl lipid (headgroup)-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Dansyl lipid (headgroup)Dansyl lipid (headgroup)-DBCO can encapsulate therapeutic agents, allowing for targeted and controlled drug delivery in oncology or other therapeutic applications.The DBCO moiety allows for the attachment of different biomolecules, creating a versatile platform for developing probes for diagnostics or therapeutic applications.	price>
R-Mcs-233	DOPS:DOPC:Chol:DOPE-N-DBCO-based Fluoroliposome NBD lipid (fatty acid tail)-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome NBD lipid (fatty acid tail)-DBCO may also be considered for use as vaccine carriers, enhancing the immune response by facilitating antigen delivery to immune cells.The incorporation of lipids that promote compatibility with biological membranes and the ability to attach therapeutic agents via the DBCO group makes these liposomes valuable for controlled drug delivery.Liposomes labeled with fluorescent or radioactive agents can be used for imaging in biomedical applications, enabling the observation of cellular uptake and distribution.	price>
R-Mcs-234	DOPS:DOPC:Chol:DOPE-N-DBCO-based Fluoroliposome NBD lipid (headgroup)-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome NBD lipid (headgroup)-DBCO is particularly suitable for targeted drug delivery because of the DBCO moiety which can enable the coupling of therapeutic agents (via azide linkers).The NBD label allows for easy tracking and visualization. This could be essential for studying pharmacokinetics, biodistribution, or cellular uptake in a variety of experimental settings.	price>
R-Mcs-235	DOPS:DOPC:Chol:DOPE-N-DBCO-based Fluoroliposome Pyrene lipid (headgroup)-DBCO	The formulation of DOPS:DOPC:Chol:DOPE-N-DBCO (20:49:30:1) fluorescent liposomes incorporating pyrene allows for an innovative platform that combines targeted drug delivery with advanced imaging capabilities. The DBCO moiety facilitates versatile bio-conjugation strategies, and the pyrene-based fluorescence enables real-time monitoring and investigation of liposomal interactions and membrane properties. This combination provides a robust approach for applications in drug delivery systems, therapeutic imaging, and fundamental studies of lipid behavior in biological systems.	price>
R-Mcs-236	DOPS:DOPC:Chol:DOPE-N-DBCO-based Fluoroliposome Rhodamine lipid (headgroup)-DBCO	The formulation of DOPS:DOPC:Chol:DOPE-N-DBCO (20:49:30:1) fluoroliposomes that incorporate a Rhodamine lipid headgroup offers a versatile platform for advanced drug delivery and bioimaging. The click chemistry functionality provided by the DBCO group enhances the conjugation capabilities with targeted therapeutics, while the rhodamine fluorescence facilitates tracking and visualization in cellular studies. These properties position this formulation as a powerful tool in both research and clinical settings, particularly in targeted therapy and molecular imaging applications.	price>
R-Mcs-237	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 5 lipid-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 5 lipid-DBCO can potentially be used in the field of theranostics, which combines therapy and diagnostics. By attaching therapeutic agents for treatment and fluorescent tags for imaging, one could monitor therapeutic responses in real time.The DBCO group allows for the covalent attachment of azide-functionalized therapeutic agents directly inside or on the surface of the liposome. This enables precise targeting strategies, potentially enhancing efficacy while reducing systemic toxicity. The Cyanine 5 lipid provides a means for non-invasive imaging, enabling visualization of liposome distribution and cellular uptake through fluorescence imaging techniques.This is particularly valuable in applications such as in vivo tumor targeting studies, tracking the biodistribution of therapeutics, or studying cellular dynamics.The strong fluorescence from the Cyanine 5 allows for real-time monitoring of liposome internalization, localization, and migration in live cells using fluorescence microscopy techniques.	price>
R-Mcs-238	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 5.5 lipid-DBCO	The DOPS:DOPC:Chol:DOPE-N-DBCO (20:49:30:1 molar ratio) based fluoroliposomes provide a versatile and effective nanoscale platform for drug delivery and bioimaging. The incorporation of Cyanine 5.5 dye allows for fluorescence-based applications, while the specific lipid composition promotes stability and biocompatibility. This formulation offers significant potential for advancements in targeted therapy and diagnostic imaging. Further optimization and exploration of conjugated biomolecules could enhance the specificity and efficacy of these liposomal carriers in clinical applications.	price>
R-Mcs-239	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 7 lipid-DBCO	DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome Cyanine 7 lipid-DBCO provides a highly versatile platform for both drug delivery and bioimaging applications. Utilize near-infrared of Cyanine 7 fluorescent properties for in vivo imaging of cells and tissues, benefiting research in cancer, cardiovascular diseases, and other biomedical fields.Functionalization with DBCO enables conjugation of targeting agents (e.g., antibodies, peptides) for enhanced specificity in drug delivery applications.Combined therapeutic and diagnostic capabilities, enabling simultaneous treatment and imaging to monitor response to therapies.	price>

...